Assembly of Hepatitis Delta Virus-like Empty Particles in Yeast  by Wu, Hui-Lin et al.
VIROLOGY 236, 374–381 (1997)
ARTICLE NO. VY978743
Assembly of Hepatitis Delta Virus-like Empty Particles in Yeast
Hui-Lin Wu,* Pei-Jer Chen,† Jung-Jung Mu,† Wei-Kuang Chi,‡ Tso-Liang Kao,†
Lih-Hwa Hwang,* and Ding-Shinn Chen*,1
*Hepatitis Research Center, National Taiwan University Hospital, †Graduate Institutes of Clinical Medicine and Microbiology,
National Taiwan University College of Medicine, and ‡Development Center for Biotechnology, Taipei, Taiwan
Received May 8, 1997; returned to author for revision June 4, 1997; accepted July 22, 1997
Large delta antigen (L-HDAg) of hepatitis delta virus (HDV) and small-form hepatitis B surface antigen (HBsAg) of helper
hepatitis B virus have previously been shown to be the minimum components for the assembly of HDV-like particles in
mammalian cells. Extending from this finding, we coexpressed L-HDAg and small HBsAg in Saccharomyces cerevisiae to
study their assembly in yeast cells. The assembly of virus particles from L-HDAg and HBsAg in yeast was demonstrated
by their coexistence in the same isopycnic fractions and by the coimmunoprecipitation of L-HDAg with HBsAg using an
antibody against HBsAg (anti-HBs). Furthermore, after purification by affinity chromatography with anti-HBs, HDV-like parti-
cles with size and morphology similar to those derived from mammalian cells could be visualized by electron microscopy.
Mice immunized with yeast-derived HDV-like particles simultaneously acquired antibodies against HBsAg and HDAg, indicat-
ing that both viral proteins are antigenic. The results indicated that S. cerevisiae could serve as a host for the assembly of
HDV-like empty particles. This system may be useful in investigating cellular processes involved in HDV assembly and in
producing ample amount of HDV-like particles for structural and immunological studies. q 1997 Academic Press
essential for virion assembly (Chao et al., 1990; ChangINTRODUCTION
et al., 1991).
Hepatitis delta virus (HDV) is a defective human patho- Since the host range of hepadnaviruses, and hence
gen causing severe acute liver inflammation or progres- the HDV, is very restricted, tissue culture cells have been
sive chronic liver diseases (Rizzetto and Verme, 1985). It a convenient system for the study of the assembly of
requires a hepadnavirus helper, the human hepatitis B HDV. Cotransfection of HBV- and HDV-expressing plas-
virus (HBV) or the woodchuck hepatitis B virus, to provide mids into mammalian cell lines has yielded HDV particles
envelope proteins for virion assembly and transmission in vitro (Wu et al., 1991; Ryu et al., 1992). Furthermore,
(Rizzetto et al., 1980; Ponzetto et al., 1984). L-HDAg along with the small form of HBsAg is necessary
The virion of HDV is a 36-nm particle, with an envelope and sufficient for the assembly of HDV-like particles de-
composed of lipid coat and three forms of hepatitis B void of viral RNA (Chang et al., 1991; Wang et al., 1991;
virus surface antigen (HBsAg) (Bonino et al., 1986; He et Ryu et al., 1992). On the other hand, S-HDAg alone can
al., 1989), termed large, middle, and small HBsAg ac- not interact with HBsAg and thus will not be packaged
cording to their protein sizes (Ganem and Varmus, 1987). into particles. Nevertheless, it can be copackaged
Inside the envelope is the 1.7-kb circular RNA genome through protein–protein interactions with L-HDAg (Chen
and two forms of HDV-specific proteins, namely the small et al., 1992).
(24 kDa) and the large (27 kDa) delta antigens (S- and Although HDV can be assembled in mammalian cells,
L-HDAg) (Bonino et al., 1986; Kos et al., 1986; Wang et mass production of HDV particles using this system is
al., 1986). L-HDAg is identical to S-HDAg except that not practical. Since HBsAg particles can be assembled
it contains a 19-amino-acid extension at the carboxyl in yeast (Valenzuela et al., 1982; Hitzeman et al., 1983)
terminus as a result of an RNA editing event which elimi- but not in bacteria (Edman et al., 1981; Mackay et al.,
nates the termination codon of S-HDAg (Luo et al., 1990). 1981), we explored the possibility of using yeast, Sac-
Although sharing similar biochemical properties, these charomyces cerevisiae, as an alternative host for the as-
two proteins play different roles in the viral life cycle. S- sembly of HDV-like particles. The yeast expression sys-
HDAg is required for HDV RNA replication (Kuo et al., tem has been used successfully not only for the assem-
1989), whereas L-HDAg inhibits the replication and is bly of HBsAg particles but also for that of the HBV-like
particles (Shiosaki et al., 1991) and the L1, L2-containing
particles of human papillomavirus (Hofmann et al., 1995).
1 To whom correspondence and reprint requests should be ad- Importantly, yeast cells have appropriate machineries todressed at the Hepatitis Research Center, National Taiwan University
carry out posttranslational modifications which may beHospital, 7 Chung-Shan South Road, Taipei, Taiwan. Fax: 886-2-
3317624 or 3825962. required for producing biologically active proteins. Estab-
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lishment of yeast as an alternative host for the assembly Transfection of DNA
of HDV-like particles would make large-scale production
Transfection of HuH-7 cells was performed by the cal-of these particles possible. These particles can then
cium phosphate precipitation method as described pre-serve many purposes, such as immunological and struc-
viously (Wu et al., 1991).tural studies.
In this communication, we report the coexpression of
Transformation of plasmid DNA into yeast cells
L-HDAg and HBsAg in yeast and the assembly of these
two proteins into HDV-like particles as characterized by Plasmid DNA was introduced into yeast using lithium
isopycnic centrifugation, coimmunoprecipitation, and chloride according to the methods developed previously
electron microscopy. with some modifications (Gietz et al., 1992). To coexpress
two proteins in a yeast cell, pGAD/L-HDAg or pGAD/S-
HDAg was cotransformed with pGPD/S into yeast cells
MATERIALS AND METHODS and the cotransformants were selected in SD synthetic
medium lacking leucine and tryptophan.
Strains
Preparation of yeast extracts
Escherichia coli DH5a was used for all bacterial trans-
Transformed yeast cells were first cultured informations. Yeast strain HF7C (MATa, ura 3-52, his 3-
Leu0Trp0 SD synthetic medium overnight, transferred to100, ade 2-101, lys 2-801, trp 1-901, leu 2-3, 112, canr,
10-fold volume of YEPD medium (1% yeast extract, 2%gal 4-542, gal 80-538, URA 3: :GAL 1-lac Z) was pur-
peptone, 2% glucose), and cultured at 307 to midlogchased from Clontech (Palo Alto, CA) and used as a host
phase or for about 20 hr for large-scale preparation. Cellscell for the expression of viral proteins.
were collected by centrifugation (2000 g, 5 min), resus-
pended in Pi/NaCl (10 mM sodium phosphate, 0.85%Plasmids NaCl) with 0.1% Triton X-100, and broken by 1 min of
vigorous vortexing with glass beads (0.45–0.60 mm;
Plasmid pSVDAg-L (Chang et al., 1991) is a mammalian
Sigma, St. Louis, MO) four times with intermittent cooling
vector expressing L-HDAg. pSX-N is a derivative of
on ice or in Dyno Mill KDL (Batch) (3000 rpm, 8 min). The
pDPSX (Wang et al., 1991). The consensus motif for N-
lysates were clarified by centrifugation at 10,000 g for 10
linked glycosylation in pSX-N has been mutated, so that
min at 47 and the supernatants were collected for analy-
it expresses only the unglycosylated form of small HBsAg
sis or further purification.
in mammalian cells (Wang et al., 1996).
To construct and express proteins of interest in yeast, Immunoblot analysis and immunoprecipitation of
two cloning vectors, pGPD (for HBsAg) and pGAD424 proteins
(Clontech) (for S-HDAg and L-HDAg) were used. They
are yeast S. cerevisiae–E. coli shuttle vectors containing Aliquots of protein extracts from transformed cells
were subjected to electrophoresis on 12% polyacryl-promoters of yeast genes (the glyceraldehyde-3-phos-
phate dehydrogenase gene promoter in pGPD and the amide gels. The gels were either stained by BM fast
staining (Boehringer Mannheim) for total protein detec-alcohol dehydrogenase gene promoter in pGAD424).
They also carry different nutritional genes (TRP 1 in pGPD tion or transferred electrophoretically to a nitrocellulose
filter (Hybond-C; Amersham, Buckinghamshire, UK) andand LEU 2 in pGAD424) that allow yeast auxotrophs to
grow on synthetic media lacking tryptophan or leucine. subjected to immunoblotting as described before (Chang
et al., 1991; Wang et al., 1996).For the construction of pGPD/S (Fig. 1A) expressing small
HBsAg in yeast, a 962-bp EcoRI–HpaI fragment of HBV Immunoprecipitations were performed with either anti-
HBs (1:300 dilution) or anti-HDAg (1:500). TransformedDNA was blunted with the Klenow fragment of DNA poly-
merase I and subcloned into pGPD that had been treated yeast cells were grown and disrupted, as described in
the previous section, in immunoprecipitation buffer (50with XhoI plus EcoRI and blunted with the Klenow frag-
ment. To express S-HDAg and L-HDAg, DNA fragments mM Tris–HCl, pH 8.0, 150 mM NaCl, 5 mM EDTA, and
0.1% Triton X-100). Protein extracts were incubated withcontaining S- or L-HDAg open reading frame were gener-
ated from pSVDAg-S (Kuo et al., 1989) or pSVDAg-L the specific antibody for 60 min, followed by addition of
30 ml of a 50% protein G-conjugated agarose for another(Chang et al., 1991) by either ScaI plus SalI or ScaI plus
PstI digestion. Both fragments were blunted and sub- 60 min. The precipitate was washed three times with
the same buffer and antigen–antibody complexes werecloned into a modified pGAD424 from which the 680-bp
HindIII–HindIII fragment had been deleted to remove eluted from the agarose beads by boiling in 11 Laemmli
loading buffer (0.0625 M Tris–HCl, pH 6.8, 2% SDS, 10%the GAL4-DNA-activation domain, and the resultant ends
were filled in with the Klenow fragment. The resulting v/v glycerol, 0.1 M DTT) for 5 min. The eluted products
were then examined by immunoblotting with anti-HDAgplasmids were designated pGAD/S-HDAg and pGAD/L-
HDAg, respectively (Fig. 1A). or anti-HBs antibody.
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FIG. 1. (A) Plasmid maps of pGPD/S, pGAD/S-HDAg, and pGAD/L-HDAg for the expression of HBsAg, L-HDAg, and S-HDAg, respectively, in
yeast. P(ADH) and T(ADH) represent the promoter and terminator of the yeast alcohol dehydrogenase gene. P(GPD) represents the promoter of the
glyceraldehyde-3-phosphate dehydrogenase gene. Letter ‘‘b’’ in parentheses indicates that the restriction enzyme-digested ends were blunted with
Klenow enzyme. (B and C) Immunoblotting analysis of HDAg and HBsAg in transformed yeast cells. 50 mg of total proteins from transformed yeast
cells or transfected HuH-7 cells was subjected to immunoblotting analysis with either anti-HDAg antiserum (B) or anti-HBsAg antibody (C). Lanes
1, 2, and 3 were protein extracts from cells cotransformed with pGPD/S and pGAD/L-HDAg (lane 1), pGPD/S and pGAD/S-HDAg (lane 2), and
untransformed cells (lane 3), respectively. Lane 4 was the cell lysate of HuH-7 cells cotransfected with pSVDAg-L and pSX-N.
Cesium chloride gradient analysis of yeast lysates centrifuged in an SW 28 rotor at 25,000 rpm, 47 for 16 hr.
The pellets were resuspended in 100 mM phosphate
The clarified lysates of transformed cells were layered buffer (pH 8.0) and then loaded onto a column of Seph-
on a 20% sucrose cushion and then centrifuged in an arose 4B conjugated with mouse anti-HBs antibody.
SW 28 (Model L-8 M; Beckman) rotor at 25,000 rpm for The absorbed antigens (and particles) were eluted with
16 hr. The pellet was dissolved in 0.5 ml Pi/NaCl, layered 3 M sodium thiocyanate/0.1 M sodium chloride, then
onto a discontinuous cesium chloride gradient (1.1–1.4 desalted and concentrated by a Centricon-30 (Amicon,
g/cm3), and centrifuged at 35,000 rpm in an SW 41 rotor Beverly, MA).
for 24 hr. Fractions of 0.5 ml were collected from the Samples purified from affinity chromatography were
bottom, diluted with five volumes of Pi/NaCl, and centri- negatively stained with 2% potassium phosphotungstic
fuged in a TLA 100.3 rotor (TL-100; Beckman) at 60,000 acid and examined by electron microscopy (Hitachi,
rpm for 2 hr, and the resulting pellets were resuspended H7100).
in Pi/NaCl. The presence of HBsAg and HDAg in each
fraction was then assayed by immunoblotting.
Expression and purification of recombinant S-HDAg in
E. coliAffinity chromatography and electron microscopy
The clarified protein extract of transformed cells or The HDV cDNA fragment from nucleotides 1598–1012
was amplified by polymerase chain reaction and sub-culture supernatant from transfected HuH-7 cells was
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cloned into a pET15a vector (Novagen, Madison, WI).
The resulting plasmid was transformed into E. coli
BL21(DE3) to express a recombinant S-HDAg having N-
terminal His-Tag by induction with 1 mM isopropyl-b-
D-thiogalactopyranoside. The recombinant S-HDAg was
purified by affinity chromatography with a nickel column
(Novagen) and then continuous elution gel electrophore-
sis (Prep Cell, Model 491; Bio-Rad, Hercules, CA) as
described in the manufacturer’s instructions.
Immunization of mice and assay of antibodies
Six-week-old female Balb/c mice were injected with
one of the following antigens: (i) 20 mg protein extract
from untransformed yeast cells; (ii) affinity-purified HDV-
like empty particles in different amounts: one contained
400 ng HBsAg and 20 ng L-HDAg and the other contained
200 ng HBsAg and 10 ng L-HDAg; or (iii) 1 mg purified
recombinant S-HDAg derived from E. coli. Antigens were
emulsified with complete Freund’s adjuvant and inocu-
lated into the mice intraperitoneally. The mice were
boosted once with the same antigen preparations in in-
complete Freund’s adjuvant 4 weeks later. Serum speci-
mens were collected on day 14 after the booster and
assayed for specific antibodies.
The murine serum specimens were diluted in 1:100 to
detect anti-HBs by a commercial enzyme immunoassay
kit (Ausab EIA Diagnostic Kit; Abbott Laboratories, North
Chicago, IL). Antibody to HDAg was assayed by enzyme-
linked immunosorbent assay (ELISA) with purified HDAg
following standard procedures. Recombinant S-HDAg
purified from E. coli was adsorbed to wells of a microtiter
plate at a concentration of 5 mg/ml (100 ml/well) in car-
bonate coating buffer (60 mM Na2CO3 , 35 mM NaHCO3 ,
pH 9.6) at 47 overnight. Mouse sera at 1:100 dilution were
added to the wells and incubated at 377 for 2 hr. For
color development, goat anti-mouse antibody conjugated
with horseradish peroxidase (Amersham) at 1:2000 and
the substrate (o-phenylenediamine and H2O2) were
FIG. 2. Cesium chloride gradient centrifugation analysis of the ly-added sequentially to the plates. Colorimetric quantita-
sates from yeast cells cotransformed with either pGPD/S and pGAD/tion was then performed with a ELISA reader (Model S
L-HDAg (A) or pGPD/S and pGAD/S-HDAg (B). The profile of density960; Metertech, Taipei).
(top) and results of immunoblotting analysis of HDAg and HBsAg in
each fraction (bottom) are shown. The number of each lane represents
the fraction number of the CsCl density equilibrium centrifugation.RESULTS AND DISCUSSION
Coexpression of HBsAg and L-HDAg or S-HDAg in
(Fig. 1C, lane 1) or S-HDAg and HBsAg (lanes 2 in Figs.yeast cells
1B and 1C) were expressed in cotransformed cells. Con-
sistent with previous reports, only a single band corre-To examine whether yeast S. cerevisiae can serve as
an alternative host for HDV assembly, we first coex- sponding to the size of unglycosylated small HBsAg was
detected (Valenzuela et al., 1982; Hitzeman et al., 1983),pressed L-HDAg and small HBsAg in yeast cells. Yeast
cells were cotransformed with either pGPD/S and pGAD/ indicating that most molecules of the small HBsAg in
yeast were not glycosylated. No signal was detected inL-HDAg or pGPD/S and pGAD/S-HDAg (as a negative
control for the assembly) and selected in synthetic media extracts derived from untransformed yeast cells (lanes
3, Figs. 1B and 1C). For comparison, lysates from HuH-lacking tryptophan and leucine for cotransformants. Ly-
sates from cells growing on selective media were then 7 cells cotransfected with plasmids expressing L-HDAg
(pSVLDAg-L) and unglycosylated form of small HBsAgassayed for the presence of HBsAg and HDAg by immu-
noblot analysis. Both L-HDAg (Fig. 1B, lane 1) and HBsAg (SX-N) were also analyzed (lanes 4 in Figs. 1B and 1C).
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FIG. 3. Immunoprecipitation of yeast lysates with anti-HBs (A) or anti-HDAg antiserum (B). The crude extracts of transformed yeast cells were
immunoprecipitated with specific antibodies and the immunoprecipitates were subjected to immunoblotting analysis with human anti-HDAg antibody
(top) or mouse anti-HBs antibody (bottom). Lanes 1, L- and S-HDAgs from HuH-7 cells as a positive control. Lanes 2, immunoprecipitates from
yeast cells cotransformed with pGPD/S and pGAD/L-HDAg. Lanes 3, immunoprecipitates from yeast cells cotransformed with pGPD/S and pGAD/
S-HDAg. Heavy chain and light chain in B represent the heavy and light chains of human immunoglobulins from human anti-HDAg antibody in
immunoprecipitation.
The viral proteins expressed in yeast cells have mobility tated with anti-HBs. The immunoprecipitates were then
separated by SDS–PAGE and analyzed by immunoblot-in SDS–PAGE gels similar to that of those expressed in
mammalian cells. The yield of HBsAg was estimated by ting. As shown in Fig. 3A, L-HDAg could be coimmuno-
precipitated with HBsAg by anti-HBs (lane 2), indicatingELISA (Auszyme, Abbott) and that of HDAg by Western
blot. The amounts of HBsAg and L-HDAg were about 0.1 that L-HDAg could interact with HBsAg to form HDV-like
empty particles in the yeast system. As a control, anti-and 0.01–0.05%, respectively, of total cellular proteins.
The result of HBsAg was comparable to those of other HBs failed to coimmunoprecipitate S-HDAg with HBsAg
(lane 3), suggesting that S-HDAg alone was not pack-studies (Valenzuela et al., 1982; Hitzeman et al., 1983).
aged into HBsAg particles, similar to the finding in the
mammalian system. In contrast, HBsAg could not be pre-Characterization and electron microscopic study of
cipitated with anti-HDAg (Fig. 3B, bottom, lane 2), sug-particles purified from yeast
gesting that packaged L-HDAg was inside the HBsAg
To examine whether HBsAg and L-HDAg can be as- particles and thus could not interact with anti-HDAg anti-
sembled into HDV-like empty particles in yeast, crude body. However, L-HDAg from cotransformed yeast cells
extracts from cotransformed yeast cells were subjected could still be immunoprecipitated by anti-HDAg antibody
to CsCl equilibrium centrifugation. After centrifugation, (Fig. 3B, top, lane 2), implying that not all L-HDAg was
fractions were collected and each was assayed for the inside the particles. These free forms of L-HDAg may
presence of specific proteins by immunoblotting. As result from the unassembled L-HDAg or from disruption
shown in Fig. 2A, in the extracts from cells cotransformed of particles during the protein extraction process.
with pGPD/S and pGAD/L-HDAg, HBsAg and L-HDAg Isoprenylation of L-HDAg at the C terminus has been
were found in the same isopycnic fractions (fractions 12 – shown to be indispensable for the interactions between
13) with a density of around 1.20 g/cm3. It appears that L-HDAg and HBsAg and hence the formation of HDV
fraction 14 contained only HBsAg, suggesting that most particles (Glenn et al., 1992; Hwang and Lai, 1993). As-
of the particles in this fraction were empty HBsAg parti- sembly of HDV-like particles in yeast as we have re-
cles. The buoyant density of fraction 14 is approximately ported here implied that L-HDAg synthesized in yeast
1.18 g/cm3, consistent with the previously reported re- was isoprenylated. Yeast farnesyltransferase (FTase)
sults of the serum- and yeast-derived empty HBsAg parti- has been known to be biochemically similar to mamma-
cles (Hitzeman et al., 1983). As a control (Fig. 2B), only lian FTase (Omer and Gibbs, 1994) which farnesylates
HBsAg, and no S-HDAg, could be detected in the isopyc- HDAg in vitro and in animal cells (Otto and Casey, 1996).
nic fractions around 1.20 g/cm3 in the extracts from cells Furthermore, our results also suggested that, like in the
cotransformed with pGPD/S and pGAD/S-HDAg. case of HBsAg particle formation (Valenzuela et al.,
To further demonstrate that L-HDAg is indeed assem- 1982), glycosylation of HBsAg is not essential for the
bled into HBsAg particles in yeast, coimmunoprecipita- formation of HDV-like particles. The observations are
tion assay was performed. Protein extracts from cells consistent with our recent results in human hepatoma
cotransformed with either pGPD/S and pGAD/L-HDAg or cell lines (Wang et al., 1996).
Yeast-derived HBsAg-containing proteins purified by af-pGPD/S and pGAD/S-HDAg were first immunoprecipi-
AID VY 8743 / 6a46$$$263 09-02-97 08:48:50 viral AP: VY
379HDV-LIKE EMPTY PARTICLES IN YEAST
FIG. 4. Electron microscopic examination of HBsAg-containing particles derived from yeast. (Left) Electron micrograph of particles purified by
immunoaffinity chromatography from yeast cells cotransformed with pGPD/S and pGAD/L-HDAg (A), culture supernatant of HuH-7 cells cotransfected
with pSVDAg-L and pSX-N (B), and yeast cells cotransformed with pGPD/S and pGAD/S-HDAg (C). Purified particles were negatively stained with
phosphotungstic acid. Representative particles with a diameter larger than 30 nm are indicated by white arrowheads. (Right) Histograms of the
size distribution of particles, which were generated by measuring the diameters of 100 intact particles observed in representative fields. The particle
diameter was inferred assuming that the particles were perfect spheres.
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finity chromatography of anti-HBs antibody were examined
by electron microscopy for HDV-like particles. Particles with
diameters ranging from 20 to 37 nm were present in sam-
ples purified from yeast cells cotransformed with pGPD/S
and pGAD/L-HDAg. Figure 4A shows that these particles
could be divided into two populations; the major one is
smaller than 30 nm and peaked at 20–25 nm; the other is
larger than 30 nm and peaked around 37 nm (arrowheads
indicate representative particles). The size distribution of
particles purified from yeast was compared to that purified
from HuH-7 cells transfected with L-HDAg- and nonglyco-
sylated small HBsAg-expression vectors. The patterns ap-
pear to be very similar (compare Figs. 4A and 4B). In con-
trast, particles purified from pGPD/S- and pGAD/S-HDAg-
cotransformed yeast cells, which should consist of HBsAg
particles only, revealed only a major population peaking at
20–22 nm; no particles larger than 30 nm were observed
(Fig. 4C). The size distribution of these particles is reminis-
cent of the reported HBsAg particles in yeast (Petre et al.,
1987). We presumed that the particles with sizes around
37 nm, similar to the size of the natural virion (He et al.,
1989), were HDV-like particles, and those with sizes around
22 nm were most likely HBsAg particles.
Calculating the exact proportion of HDV-like particles
in yeast lysates was difficult due to the lack of satisfac-
tory methods to separate HDV-like and HBsAg empty
particles and also the uncertainty regarding the molar
ratio of HBsAg to L-HDAg in an HDV-like empty particle.
However, by electron microscopic observation, HDV-like
particles were roughly estimated to constitute about 5–
10% of total particles in both yeast and mammalian prep-
arations. By SDS–PAGE analysis, the ratio of L-HDAg to FIG. 5. Detection of HDAg- and HBsAg-specific antibodies in immu-
HBsAg in purified particles, as estimated by the signal nized Balb/c mice. Antibodies to HDAg (top) and to HBsAg (bottom)
were detected by ELISA as described under Materials and Methods.strength of staining, is 0.12 and 0.1 for yeast- and mam-
The y axis depicts optical densities of the ELISA.malian cell-derived particles, respectively. The packag-
ing efficiency of HDV-like empty particles in yeast system
thus appears to be similar to that in mammalian cells. ing susceptible woodchucks or chimpanzees with re-
combinant S-HDAg may limit the level of hepatitis D
Induction of antibodies to both HBsAg and HDAg by viremia, but failed to protect the animals (Kos et al., 1991;
HDV-like empty particles from yeast Karayiannis et al., 1993). However, the recombinant
HDAg used in previous studies were all free polypep-
The immunogenicity of yeast-derived HDV-like empty tides. As intact HBsAg particles have been known to be
particles was tested in mice. Sera of the mice immunized more immunogenic than free proteins (Cabral et al.,
with yeast-derived HDV-like particles were demonstrated 1978), HDAg in particle forms may also yield a better
to contain antibodies against both HDAg and HBsAg by immunogenicity. Our results in mice indicated that the
ELISA (Fig. 5). The specificity of these antibodies was yeast-derived HDV-like particles were quite immuno-
confirmed by immunoblot analysis (data not shown). As genic. Thus, the successful assembly of HDV-like parti-
a control, mice immunized with either purified S-HDAg cles in yeast may be used for the production of large
from E. coli lysates or crude extracts of untransformed amounts of these particles for further studies in suscepti-
yeast cells produced antibody against HDAg only or no ble animals, such as woodchucks, to examine their im-
antibody against HDAg and HBsAg, respectively (Fig. 5). munogenicity and protective efficacy as a potential vac-
The results indicated that the yeast-derived HDV-like par- cine.
ticles were immunogenic in eliciting humoral immunity
against both HDAg and HBsAg in mice.
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